Bruce C Anderson

Array ( [id] => 6973390 [patent_doc_number] => 20010003588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-06-14 [patent_title] => 'Controlled release dosage form of [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo[2.2.2.]oct-3-yl)acetonitrile monohydrochloride' [patent_app_type] => new-utility [patent_app_number] => 09/759576 [patent_app_country] => US [patent_app_date] => 2001-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6235 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20010003588.pdf [firstpage_image] =>[orig_patent_app_number] => 09759576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6893836 [patent_doc_number] => 20010016202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-23 [patent_title] => 'Silicone-treated powder, process of production thereof and composition containing the same' [patent_app_type] => new [patent_app_number] => 09/753569 [patent_app_country] => US [patent_app_date] => 2001-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9297 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20010016202.pdf [firstpage_image] =>[orig_patent_app_number] => 09753569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6948104 [patent_doc_number] => 20010021740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-13 [patent_title] => 'Low viscosity filler composition of boron nitride particles of spherical geometry and process' [patent_app_type] => new [patent_app_number] => 09/754154 [patent_app_country] => US [patent_app_date] => 2001-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3569 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20010021740.pdf [firstpage_image] =>[orig_patent_app_number] => 09754154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5921195 [patent_doc_number] => 20020114843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Preparation of microparticles having improved flowability' [patent_app_type] => new [patent_app_number] => 09/748136 [patent_app_country] => US [patent_app_date] => 2000-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5582 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20020114843.pdf [firstpage_image] =>[orig_patent_app_number] => 09748136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843652 [patent_doc_number] => 20020132010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Divalproex sodium dosage forms and a process for their production' [patent_app_type] => new [patent_app_number] => 09/747912 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9398 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132010.pdf [firstpage_image] =>[orig_patent_app_number] => 09747912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6902130 [patent_doc_number] => 20010001039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-05-10 [patent_title] => 'Methods and compositions for the treatment of wounds' [patent_app_type] => new-utility [patent_app_number] => 09/747742 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8379 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20010001039.pdf [firstpage_image] =>[orig_patent_app_number] => 09747742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6875266 [patent_doc_number] => 20010000469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-04-26 [patent_title] => 'Use of 17-alpha-estradiol for the treatment of aged or sun-damaged skin and/or skin atrophy' [patent_app_type] => new-utility [patent_app_number] => 09/740253 [patent_app_country] => US [patent_app_date] => 2000-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2556 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0000/20010000469.pdf [firstpage_image] =>[orig_patent_app_number] => 09740253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1564242 [patent_doc_number] => 06375987 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Process for the manufacture of pharmaceutical composition with modified release of active principle comprising the matrix' [patent_app_type] => B1 [patent_app_number] => 09/718613 [patent_app_country] => US [patent_app_date] => 2000-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 4766 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/375/06375987.pdf [firstpage_image] =>[orig_patent_app_number] => 09718613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1301254 [patent_doc_number] => 06620425 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-16 [patent_title] => 'Food supplements and methods comprising lipoic acid and creatine' [patent_app_type] => B1 [patent_app_number] => 09/666432 [patent_app_country] => US [patent_app_date] => 2000-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2847 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/620/06620425.pdf [firstpage_image] =>[orig_patent_app_number] => 09666432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1399230 [patent_doc_number] => 06531490 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-11 [patent_title] => 'Production of agglomerates of inogatran and the compound inogatran anhydrate' [patent_app_type] => B1 [patent_app_number] => 09/646440 [patent_app_country] => US [patent_app_date] => 2000-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2317 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531490.pdf [firstpage_image] =>[orig_patent_app_number] => 09646440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493284 [patent_doc_number] => 06403066 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Use of a guar gum in a process for the temporary shaping of keratin fibers' [patent_app_type] => B1 [patent_app_number] => 09/650193 [patent_app_country] => US [patent_app_date] => 2000-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2493 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403066.pdf [firstpage_image] =>[orig_patent_app_number] => 09650193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1527531 [patent_doc_number] => 06479078 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Substantially crystalline form of melagatran' [patent_app_type] => B1 [patent_app_number] => 09/623165 [patent_app_country] => US [patent_app_date] => 2000-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7832 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479078.pdf [firstpage_image] =>[orig_patent_app_number] => 09623165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1211910 [patent_doc_number] => 06709667 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-23 [patent_title] => 'Deployment actuation system for intrafallopian contraception' [patent_app_type] => B1 [patent_app_number] => 09/644287 [patent_app_country] => US [patent_app_date] => 2000-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 47 [patent_no_of_words] => 10952 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/709/06709667.pdf [firstpage_image] =>[orig_patent_app_number] => 09644287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1516391 [patent_doc_number] => 06500457 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent' [patent_app_type] => B1 [patent_app_number] => 09/639584 [patent_app_country] => US [patent_app_date] => 2000-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13414 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500457.pdf [firstpage_image] =>[orig_patent_app_number] => 09639584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1392616 [patent_doc_number] => 06537580 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Stable shaped particles of crystalline organic compounds' [patent_app_type] => B1 [patent_app_number] => 09/615061 [patent_app_country] => US [patent_app_date] => 2000-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7046 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537580.pdf [firstpage_image] =>[orig_patent_app_number] => 09615061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1260458 [patent_doc_number] => 06663878 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-16 [patent_title] => 'Anti-inflammatory bioactive glass particulates' [patent_app_type] => B1 [patent_app_number] => 09/560475 [patent_app_country] => US [patent_app_date] => 2000-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4589 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/663/06663878.pdf [firstpage_image] =>[orig_patent_app_number] => 09560475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1298000 [patent_doc_number] => 06623752 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-23 [patent_title] => 'Patch for transdermal application for pergolid' [patent_app_type] => B1 [patent_app_number] => 09/550926 [patent_app_country] => US [patent_app_date] => 2000-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1120 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/623/06623752.pdf [firstpage_image] =>[orig_patent_app_number] => 09550926 [rel_patent_id] =>[rel_patent_doc_number] =>)